

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | nuclear pore complex assembly (GO:0051292) | 4.75144641 |
| 2 | pre-miRNA processing (GO:0031054) | 4.70106169 |
| 3 | heterochromatin organization (GO:0070828) | 4.41803709 |
| 4 | cellular protein complex localization (GO:0034629) | 4.22621800 |
| 5 | nuclear pore organization (GO:0006999) | 4.05920102 |
| 6 | mitotic sister chromatid cohesion (GO:0007064) | 3.97263801 |
| 7 | mitotic chromosome condensation (GO:0007076) | 3.91017751 |
| 8 | DNA unwinding involved in DNA replication (GO:0006268) | 3.89722318 |
| 9 | protein localization to chromosome, centromeric region (GO:0071459) | 3.78716911 |
| 10 | regulation of histone H3-K9 methylation (GO:0051570) | 3.78045451 |
| 11 | protein complex localization (GO:0031503) | 3.75970011 |
| 12 | protein localization to kinetochore (GO:0034501) | 3.75280773 |
| 13 | negative regulation of histone methylation (GO:0031061) | 3.74742818 |
| 14 | pore complex assembly (GO:0046931) | 3.73736898 |
| 15 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 3.66106208 |
| 16 | regulation of cytokine secretion involved in immune response (GO:0002739) | 3.64956352 |
| 17 | regulation of vitamin D biosynthetic process (GO:0060556) | 3.61676921 |
| 18 | DNA topological change (GO:0006265) | 3.42053653 |
| 19 | regulation of RNA export from nucleus (GO:0046831) | 3.29713350 |
| 20 | folic acid-containing compound biosynthetic process (GO:0009396) | 3.29156531 |
| 21 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.25620011 |
| 22 | regulation of chronic inflammatory response (GO:0002676) | 3.18779560 |
| 23 | DNA strand elongation (GO:0022616) | 3.16331867 |
| 24 | DNA replication checkpoint (GO:0000076) | 3.14384392 |
| 25 | mitotic metaphase plate congression (GO:0007080) | 3.12359058 |
| 26 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.11210657 |
| 27 | regulation of NFAT protein import into nucleus (GO:0051532) | 3.05650407 |
| 28 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.05405834 |
| 29 | mitotic G2/M transition checkpoint (GO:0044818) | 3.05353548 |
| 30 | positive regulation of chromosome segregation (GO:0051984) | 3.04853317 |
| 31 | cardiac myofibril assembly (GO:0055003) | 3.02959598 |
| 32 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.99737025 |
| 33 | T cell lineage commitment (GO:0002360) | 2.97645511 |
| 34 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.96085326 |
| 35 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.92020694 |
| 36 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.90503124 |
| 37 | regulation of interferon-alpha production (GO:0032647) | 2.86843872 |
| 38 | mitotic nuclear envelope disassembly (GO:0007077) | 2.86056199 |
| 39 | plasma membrane repair (GO:0001778) | 2.84833018 |
| 40 | histone H3-K36 demethylation (GO:0070544) | 2.84320658 |
| 41 | nuclear envelope disassembly (GO:0051081) | 2.83327053 |
| 42 | membrane disassembly (GO:0030397) | 2.83327053 |
| 43 | DNA replication initiation (GO:0006270) | 2.81374657 |
| 44 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.79708341 |
| 45 | negative regulation of translation, ncRNA-mediated (GO:0040033) | 2.79573194 |
| 46 | regulation of translation, ncRNA-mediated (GO:0045974) | 2.79573194 |
| 47 | negative regulation of translation involved in gene silencing by miRNA (GO:0035278) | 2.79573194 |
| 48 | regulation of vitamin metabolic process (GO:0030656) | 2.79039321 |
| 49 | negative regulation of DNA repair (GO:0045738) | 2.78411386 |
| 50 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.76851509 |
| 51 | mitotic G2 DNA damage checkpoint (GO:0007095) | 2.76780968 |
| 52 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.75169875 |
| 53 | sister chromatid segregation (GO:0000819) | 2.74294538 |
| 54 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.74247044 |
| 55 | mitotic sister chromatid segregation (GO:0000070) | 2.74232594 |
| 56 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.74181866 |
| 57 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.73517701 |
| 58 | growth hormone receptor signaling pathway (GO:0060396) | 2.73433370 |
| 59 | establishment of integrated proviral latency (GO:0075713) | 2.72220072 |
| 60 | cell communication involved in cardiac conduction (GO:0086065) | 2.70174145 |
| 61 | regulation of podosome assembly (GO:0071801) | 2.67783510 |
| 62 | modulation by symbiont of host cellular process (GO:0044068) | 2.67136617 |
| 63 | cellular response to virus (GO:0098586) | 2.64906099 |
| 64 | regulation of stem cell maintenance (GO:2000036) | 2.64169447 |
| 65 | chromatin remodeling at centromere (GO:0031055) | 2.64148104 |
| 66 | trophoblast giant cell differentiation (GO:0060707) | 2.63137907 |
| 67 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.62685947 |
| 68 | regulation of chromatin binding (GO:0035561) | 2.62503116 |
| 69 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.61529329 |
| 70 | IMP biosynthetic process (GO:0006188) | 2.61004358 |
| 71 | myofibril assembly (GO:0030239) | 2.58272239 |
| 72 | metaphase plate congression (GO:0051310) | 2.55494949 |
| 73 | regulation of metaphase/anaphase transition of cell cycle (GO:1902099) | 2.55118747 |
| 74 | regulation of mitotic metaphase/anaphase transition (GO:0030071) | 2.55118747 |
| 75 | cell communication by electrical coupling (GO:0010644) | 2.54889041 |
| 76 | sarcomere organization (GO:0045214) | 2.54162416 |
| 77 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.54104261 |
| 78 | regulation of fever generation (GO:0031620) | 2.53989860 |
| 79 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.51807326 |
| 80 | regulation of gene silencing by miRNA (GO:0060964) | 2.51807326 |
| 81 | regulation of gene silencing by RNA (GO:0060966) | 2.51807326 |
| 82 | activation of MAPKKK activity (GO:0000185) | 2.50556478 |
| 83 | cardiac muscle contraction (GO:0060048) | 2.50510723 |
| 84 | CENP-A containing nucleosome assembly (GO:0034080) | 2.49309311 |
| 85 | telomere maintenance via recombination (GO:0000722) | 2.49167284 |
| 86 | negative regulation of chromosome segregation (GO:0051985) | 2.49050353 |
| 87 | negative regulation of interleukin-12 production (GO:0032695) | 2.48991083 |
| 88 | regulation of sister chromatid cohesion (GO:0007063) | 2.48286928 |
| 89 | DNA duplex unwinding (GO:0032508) | 2.48237005 |
| 90 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.48133777 |
| 91 | DNA replication-independent nucleosome assembly (GO:0006336) | 2.48000474 |
| 92 | DNA replication-independent nucleosome organization (GO:0034724) | 2.48000474 |
| 93 | 2-oxoglutarate metabolic process (GO:0006103) | 2.47814277 |
| 94 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.46179140 |
| 95 | regulation of chromosome segregation (GO:0051983) | 2.45829164 |
| 96 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.45737124 |
| 97 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 2.45335549 |
| 98 | mitotic recombination (GO:0006312) | 2.44786569 |
| 99 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.44392842 |
| 100 | IMP metabolic process (GO:0046040) | 2.42458294 |
| 101 | RNA stabilization (GO:0043489) | 2.42384093 |
| 102 | mRNA stabilization (GO:0048255) | 2.42384093 |
| 103 | ribosomal small subunit biogenesis (GO:0042274) | 2.42274004 |
| 104 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.42229497 |
| 105 | purine nucleobase biosynthetic process (GO:0009113) | 2.41483143 |
| 106 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.41204075 |
| 107 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.41204075 |
| 108 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.41204075 |
| 109 | regulation of sister chromatid segregation (GO:0033045) | 2.40127188 |
| 110 | regulation of mitotic sister chromatid separation (GO:0010965) | 2.40127188 |
| 111 | regulation of mitotic sister chromatid segregation (GO:0033047) | 2.40127188 |
| 112 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 2.39929843 |
| 113 | negative regulation of DNA-dependent DNA replication (GO:2000104) | 2.37771615 |
| 114 | lysine catabolic process (GO:0006554) | 2.37627357 |
| 115 | lysine metabolic process (GO:0006553) | 2.37627357 |
| 116 | negative regulation of fibroblast apoptotic process (GO:2000270) | 2.37017652 |
| 117 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.36019670 |
| 118 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.33381033 |
| 119 | sodium ion export (GO:0071436) | 2.31048557 |
| 120 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.29880909 |
| 121 | cardiac muscle hypertrophy (GO:0003300) | 2.25302814 |
| 122 | phospholipid homeostasis (GO:0055091) | 2.24952702 |
| 123 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 2.24317014 |
| 124 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.23994721 |
| 125 | cellular response to growth hormone stimulus (GO:0071378) | 2.23933163 |
| 126 | fatty acid transmembrane transport (GO:1902001) | 2.22710985 |
| 127 | muscle hypertrophy (GO:0014896) | 2.21923646 |
| 128 | negative regulation of cell killing (GO:0031342) | 2.21885706 |
| 129 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.21885706 |
| 130 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.17959989 |
| 131 | cell adhesion mediated by integrin (GO:0033627) | 2.13468256 |
| 132 | striated muscle hypertrophy (GO:0014897) | 2.12457934 |
| 133 | negative thymic T cell selection (GO:0045060) | 2.11075394 |
| 134 | cellular response to prostaglandin stimulus (GO:0071379) | 2.10729051 |
| 135 | regulation of actin filament-based movement (GO:1903115) | 2.08932113 |
| 136 | positive regulation of muscle hypertrophy (GO:0014742) | 2.07568430 |
| 137 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.07568430 |
| 138 | negative T cell selection (GO:0043383) | 2.06960595 |
| 139 | regulation of relaxation of muscle (GO:1901077) | 2.06589116 |
| 140 | regulation of the force of heart contraction (GO:0002026) | 2.06223843 |
| 141 | positive regulation of macrophage cytokine production (GO:0060907) | 2.04570002 |
| 142 | carnitine shuttle (GO:0006853) | 2.04349876 |
| 143 | kynurenine metabolic process (GO:0070189) | 2.04252181 |
| 144 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.03904342 |
| 145 | regulation of cholesterol storage (GO:0010885) | 2.03396643 |
| 146 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.02367541 |
| 147 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.02098056 |
| 148 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.01963080 |
| 149 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.01691830 |
| 150 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.01299553 |
| 151 | relaxation of cardiac muscle (GO:0055119) | 1.99835566 |
| 152 | response to prostaglandin E (GO:0034695) | 1.97384378 |
| 153 | regulation of cell communication by electrical coupling (GO:0010649) | 1.97020770 |
| 154 | positive regulation of gamma-delta T cell activation (GO:0046645) | 1.97003610 |
| 155 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 1.96696767 |
| 156 | locomotory exploration behavior (GO:0035641) | 1.96512349 |
| 157 | regulation of T-helper 1 cell differentiation (GO:0045625) | 1.95973492 |
| 158 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 1.95746596 |
| 159 | positive regulation of glycogen biosynthetic process (GO:0045725) | 1.93368726 |
| 160 | desmosome organization (GO:0002934) | 1.93055292 |
| 161 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 1.92237317 |
| 162 | cellular ketone body metabolic process (GO:0046950) | 1.91345673 |
| 163 | regulation of p38MAPK cascade (GO:1900744) | 1.89734860 |
| 164 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 1.89344087 |
| 165 | thymic T cell selection (GO:0045061) | 1.88694685 |
| 166 | regulation of ARF protein signal transduction (GO:0032012) | 1.88495223 |
| 167 | positive regulation of lipid storage (GO:0010884) | 1.87431273 |
| 168 | positive regulation of humoral immune response (GO:0002922) | 1.86818250 |
| 169 | substrate-dependent cell migration (GO:0006929) | 1.86724073 |
| 170 | NIK/NF-kappaB signaling (GO:0038061) | 1.86410207 |
| 171 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 1.86314413 |
| 172 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 1.86029307 |
| 173 | regulation of synapse structural plasticity (GO:0051823) | 1.85287001 |
| 174 | oxaloacetate metabolic process (GO:0006107) | 1.84096353 |
| 175 | myeloid dendritic cell differentiation (GO:0043011) | 1.83871096 |
| 176 | activation of protein kinase A activity (GO:0034199) | 1.83612330 |
| 177 | I-kappaB phosphorylation (GO:0007252) | 1.83302455 |
| 178 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 1.82978533 |
| 179 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 1.82978126 |
| 180 | muscle hypertrophy in response to stress (GO:0003299) | 1.82978126 |
| 181 | cardiac muscle adaptation (GO:0014887) | 1.82978126 |
| 182 | synaptic vesicle maturation (GO:0016188) | 1.82836728 |
| 183 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 1.82747400 |
| 184 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 1.82623685 |
| 185 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 1.82623685 |
| 186 | positive regulation of antigen processing and presentation (GO:0002579) | 1.82025569 |
| 187 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 1.81381111 |
| 188 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 1.81378208 |
| 189 | endocytic recycling (GO:0032456) | 1.81376813 |
| 190 | T cell selection (GO:0045058) | 1.80416469 |
| 191 | positive regulation of p38MAPK cascade (GO:1900745) | 1.80298212 |
| 192 | actomyosin structure organization (GO:0031032) | 1.80140532 |
| 193 | cardiac conduction (GO:0061337) | 1.80077781 |
| 194 | phospholipid efflux (GO:0033700) | 1.79553856 |
| 195 | urea metabolic process (GO:0019627) | 1.79511926 |
| 196 | urea cycle (GO:0000050) | 1.79511926 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 9.70988188 |
| 2 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 4.35718016 |
| 3 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.64973181 |
| 4 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 3.63723695 |
| 5 | MYC_22102868_ChIP-Seq_BL_Human | 3.22477220 |
| 6 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.84868226 |
| 7 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.81272057 |
| 8 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.58931263 |
| 9 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.57423068 |
| 10 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 2.51953899 |
| 11 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 2.51953899 |
| 12 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 2.51953899 |
| 13 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.45293465 |
| 14 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.32923496 |
| 15 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.32028110 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.25929111 |
| 17 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 2.18116191 |
| 18 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.17601583 |
| 19 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.11049798 |
| 20 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 2.06096036 |
| 21 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.03076265 |
| 22 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.02375523 |
| 23 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.00532943 |
| 24 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.90143016 |
| 25 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.88208130 |
| 26 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.87518756 |
| 27 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.81844410 |
| 28 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.81685925 |
| 29 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.78012050 |
| 30 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.74283956 |
| 31 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.71629195 |
| 32 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.63211521 |
| 33 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.62789755 |
| 34 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.60981763 |
| 35 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.60843640 |
| 36 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.59699655 |
| 37 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.58954883 |
| 38 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.57723256 |
| 39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.54429144 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54300908 |
| 41 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.53344545 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.53136756 |
| 43 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.52263675 |
| 44 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.51246770 |
| 45 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.50834416 |
| 46 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.50493601 |
| 47 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.50233225 |
| 48 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.50217727 |
| 49 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.48420154 |
| 50 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.48284215 |
| 51 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.48266823 |
| 52 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.48266823 |
| 53 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.48089997 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.47652687 |
| 55 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.47479670 |
| 56 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.46250115 |
| 57 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.44205172 |
| 58 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.43742884 |
| 59 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.43530676 |
| 60 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.43196290 |
| 61 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.42782428 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.42614248 |
| 63 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.40581476 |
| 64 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.40182260 |
| 65 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.40007440 |
| 66 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.39235747 |
| 67 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.38752157 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.38724134 |
| 69 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38568590 |
| 70 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.38179253 |
| 71 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38153944 |
| 72 | * JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.37722365 |
| 73 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.36905658 |
| 74 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.36503203 |
| 75 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.36483466 |
| 76 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35668219 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33836123 |
| 78 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.33634768 |
| 79 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.32881328 |
| 80 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.32777953 |
| 81 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.32663465 |
| 82 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.32574586 |
| 83 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.30149773 |
| 84 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.30085727 |
| 85 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.28855650 |
| 86 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28155416 |
| 87 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.27621855 |
| 88 | * JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.27168407 |
| 89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.27061806 |
| 90 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26317797 |
| 91 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.26195532 |
| 92 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.25886436 |
| 93 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.23864137 |
| 94 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23501008 |
| 95 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.22117030 |
| 96 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.21760415 |
| 97 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.21706651 |
| 98 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.21143760 |
| 99 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21020542 |
| 100 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.21007839 |
| 101 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.20300285 |
| 102 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.20293751 |
| 103 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.20293751 |
| 104 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19923736 |
| 105 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.19367678 |
| 106 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.17006829 |
| 107 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.16906227 |
| 108 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.15480982 |
| 109 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15379572 |
| 110 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.15095389 |
| 111 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.14741373 |
| 112 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.14605108 |
| 113 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.14554777 |
| 114 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.14390821 |
| 115 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.14248288 |
| 116 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.11794502 |
| 117 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.11635824 |
| 118 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.11381656 |
| 119 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.10619152 |
| 120 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.10445639 |
| 121 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.09700350 |
| 122 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.09593426 |
| 123 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.08889679 |
| 124 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.08588581 |
| 125 | RXR_22108803_ChIP-Seq_LS180_Human | 1.08463161 |
| 126 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.08012871 |
| 127 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.07804666 |
| 128 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.07670874 |
| 129 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.07670874 |
| 130 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06911444 |
| 131 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.06879329 |
| 132 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06608079 |
| 133 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.05537218 |
| 134 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.05485511 |
| 135 | MAF_26560356_Chip-Seq_TH1_Human | 1.05376943 |
| 136 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05067906 |
| 137 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.04819650 |
| 138 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04534759 |
| 139 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.03446900 |
| 140 | GATA1_19941826_ChIP-Seq_K562_Human | 1.03396955 |
| 141 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.02421800 |
| 142 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.02006950 |
| 143 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.01494608 |
| 144 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.01248176 |
| 145 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.01239076 |
| 146 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.00010658 |
| 147 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99741356 |
| 148 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.99590285 |
| 149 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98997493 |
| 150 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98982254 |
| 151 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.98839326 |
| 152 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.98120758 |
| 153 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.97822484 |
| 154 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97227757 |
| 155 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.97079135 |
| 156 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.96436534 |
| 157 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95962050 |
| 158 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.95806254 |
| 159 | * PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.95787997 |
| 160 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.95031110 |
| 161 | MYB_26560356_Chip-Seq_TH1_Human | 0.94813097 |
| 162 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.94318161 |
| 163 | * SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94301524 |
| 164 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93172200 |
| 165 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.93058901 |
| 166 | SOX2_19030024_ChIP-ChIP_MESCs_Mouse | 0.92009071 |
| 167 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.91971768 |
| 168 | GATA1_22025678_ChIP-Seq_K562_Human | 0.91611708 |
| 169 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90982754 |
| 170 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.90536036 |
| 171 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.89771029 |
| 172 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89562139 |
| 173 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.89321955 |
| 174 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.88819649 |
| 175 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.88592688 |
| 176 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.88298925 |
| 177 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.87445261 |
| 178 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.87043198 |
| 179 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.86294481 |
| 180 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.86122408 |
| 181 | * LXR_22292898_ChIP-Seq_THP-1_Human | 0.86059739 |
| 182 | GBX2_23144817_ChIP-Seq_PC3_Human | 0.85431544 |
| 183 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.85159415 |
| 184 | GATA2_19941826_ChIP-Seq_K562_Human | 0.84208961 |
| 185 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.83861184 |
| 186 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.83676309 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004510_myositis | 3.98013075 |
| 2 | MP0008057_abnormal_DNA_replication | 3.86111569 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.04661449 |
| 4 | MP0003111_abnormal_nucleus_morphology | 2.99945898 |
| 5 | MP0003941_abnormal_skin_development | 2.92482939 |
| 6 | MP0010352_gastrointestinal_tract_polyps | 2.79548023 |
| 7 | MP0003890_abnormal_embryonic-extraembry | 2.71935899 |
| 8 | MP0002138_abnormal_hepatobiliary_system | 2.62597432 |
| 9 | MP0004957_abnormal_blastocyst_morpholog | 2.61636289 |
| 10 | MP0003656_abnormal_erythrocyte_physiolo | 2.55467536 |
| 11 | MP0004084_abnormal_cardiac_muscle | 2.53667456 |
| 12 | MP0005360_urolithiasis | 2.53054119 |
| 13 | MP0010094_abnormal_chromosome_stability | 2.44669555 |
| 14 | MP0002837_dystrophic_cardiac_calcinosis | 2.42811161 |
| 15 | MP0003453_abnormal_keratinocyte_physiol | 2.36968743 |
| 16 | MP0005076_abnormal_cell_differentiation | 2.27946302 |
| 17 | MP0003303_peritoneal_inflammation | 2.23616890 |
| 18 | MP0003705_abnormal_hypodermis_morpholog | 2.21943894 |
| 19 | MP0003077_abnormal_cell_cycle | 2.11751135 |
| 20 | MP0002254_reproductive_system_inflammat | 2.07372996 |
| 21 | MP0002139_abnormal_hepatobiliary_system | 2.05844844 |
| 22 | MP0004858_abnormal_nervous_system | 2.00907673 |
| 23 | MP0004859_abnormal_synaptic_plasticity | 1.99288703 |
| 24 | MP0008775_abnormal_heart_ventricle | 1.96456202 |
| 25 | MP0000751_myopathy | 1.95078805 |
| 26 | MP0004215_abnormal_myocardial_fiber | 1.91119903 |
| 27 | MP0002972_abnormal_cardiac_muscle | 1.87004971 |
| 28 | MP0001730_embryonic_growth_arrest | 1.86225507 |
| 29 | MP0004130_abnormal_muscle_cell | 1.84002573 |
| 30 | MP0010307_abnormal_tumor_latency | 1.83172100 |
| 31 | MP0001835_abnormal_antigen_presentation | 1.82197778 |
| 32 | MP0009278_abnormal_bone_marrow | 1.81272737 |
| 33 | MP0005085_abnormal_gallbladder_physiolo | 1.79270515 |
| 34 | MP0003436_decreased_susceptibility_to | 1.77912596 |
| 35 | MP0009333_abnormal_splenocyte_physiolog | 1.74089340 |
| 36 | MP0003646_muscle_fatigue | 1.71036229 |
| 37 | MP0003252_abnormal_bile_duct | 1.67871451 |
| 38 | MP0004185_abnormal_adipocyte_glucose | 1.65415088 |
| 39 | MP0004808_abnormal_hematopoietic_stem | 1.64384039 |
| 40 | MP0000685_abnormal_immune_system | 1.63965749 |
| 41 | MP0004036_abnormal_muscle_relaxation | 1.59440636 |
| 42 | MP0001348_abnormal_lacrimal_gland | 1.57900460 |
| 43 | MP0000490_abnormal_crypts_of | 1.57228111 |
| 44 | MP0000350_abnormal_cell_proliferation | 1.56073888 |
| 45 | MP0003763_abnormal_thymus_physiology | 1.55747755 |
| 46 | MP0002735_abnormal_chemical_nociception | 1.55098241 |
| 47 | MP0000604_amyloidosis | 1.54381637 |
| 48 | MP0001790_abnormal_immune_system | 1.53833995 |
| 49 | MP0005387_immune_system_phenotype | 1.53833995 |
| 50 | MP0005310_abnormal_salivary_gland | 1.53701378 |
| 51 | MP0009672_abnormal_birth_weight | 1.51771866 |
| 52 | MP0000569_abnormal_digit_pigmentation | 1.50382519 |
| 53 | MP0003300_gastrointestinal_ulcer | 1.49237721 |
| 54 | MP0005330_cardiomyopathy | 1.48701727 |
| 55 | MP0005083_abnormal_biliary_tract | 1.47908736 |
| 56 | MP0001544_abnormal_cardiovascular_syste | 1.46737737 |
| 57 | MP0005385_cardiovascular_system_phenoty | 1.46737737 |
| 58 | MP0001545_abnormal_hematopoietic_system | 1.43959489 |
| 59 | MP0005397_hematopoietic_system_phenotyp | 1.43959489 |
| 60 | MP0002796_impaired_skin_barrier | 1.40746919 |
| 61 | MP0005671_abnormal_response_to | 1.38179609 |
| 62 | MP0008007_abnormal_cellular_replicative | 1.37820583 |
| 63 | MP0006138_congestive_heart_failure | 1.35308817 |
| 64 | MP0004087_abnormal_muscle_fiber | 1.33798018 |
| 65 | MP0003123_paternal_imprinting | 1.32168854 |
| 66 | MP0003566_abnormal_cell_adhesion | 1.32005045 |
| 67 | MP0002398_abnormal_bone_marrow | 1.31870614 |
| 68 | MP0005167_abnormal_blood-brain_barrier | 1.30855830 |
| 69 | MP0004484_altered_response_of | 1.30509501 |
| 70 | MP0010630_abnormal_cardiac_muscle | 1.29178197 |
| 71 | MP0005365_abnormal_bile_salt | 1.27930448 |
| 72 | MP0000749_muscle_degeneration | 1.26619696 |
| 73 | MP0009840_abnormal_foam_cell | 1.26527009 |
| 74 | MP0008058_abnormal_DNA_repair | 1.26130454 |
| 75 | MP0003828_pulmonary_edema | 1.25959581 |
| 76 | MP0002405_respiratory_system_inflammati | 1.24559997 |
| 77 | MP0009764_decreased_sensitivity_to | 1.23154159 |
| 78 | MP0003279_aneurysm | 1.22914779 |
| 79 | MP0002148_abnormal_hypersensitivity_rea | 1.21646693 |
| 80 | MP0001697_abnormal_embryo_size | 1.21002121 |
| 81 | MP0001672_abnormal_embryogenesis/_devel | 1.20341567 |
| 82 | MP0005380_embryogenesis_phenotype | 1.20341567 |
| 83 | MP0008961_abnormal_basal_metabolism | 1.20142338 |
| 84 | MP0003091_abnormal_cell_migration | 1.19398602 |
| 85 | MP0000313_abnormal_cell_death | 1.18221558 |
| 86 | MP0008004_abnormal_stomach_pH | 1.17895192 |
| 87 | MP0005000_abnormal_immune_tolerance | 1.17421050 |
| 88 | MP0003984_embryonic_growth_retardation | 1.16079786 |
| 89 | MP0000689_abnormal_spleen_morphology | 1.15898411 |
| 90 | MP0005620_abnormal_muscle_contractility | 1.15582616 |
| 91 | MP0008932_abnormal_embryonic_tissue | 1.14822316 |
| 92 | MP0002088_abnormal_embryonic_growth/wei | 1.14681262 |
| 93 | MP0000703_abnormal_thymus_morphology | 1.13284449 |
| 94 | MP0003191_abnormal_cellular_cholesterol | 1.12683188 |
| 95 | MP0004947_skin_inflammation | 1.11299330 |
| 96 | MP0003448_altered_tumor_morphology | 1.10757436 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 1.10500166 |
| 98 | MP0002722_abnormal_immune_system | 1.10359849 |
| 99 | MP0010368_abnormal_lymphatic_system | 1.08273509 |
| 100 | MP0005058_abnormal_lysosome_morphology | 1.06623628 |
| 101 | MP0004085_abnormal_heartbeat | 1.06094969 |
| 102 | MP0002166_altered_tumor_susceptibility | 1.04085376 |
| 103 | MP0001968_abnormal_touch/_nociception | 1.03774359 |
| 104 | MP0002998_abnormal_bone_remodeling | 1.01128844 |
| 105 | MP0000343_altered_response_to | 1.01058359 |
| 106 | MP0002080_prenatal_lethality | 1.00311518 |
| 107 | MP0002086_abnormal_extraembryonic_tissu | 0.99944345 |
| 108 | MP0003137_abnormal_impulse_conducting | 0.99344551 |
| 109 | MP0003075_altered_response_to | 0.97932653 |
| 110 | MP0000716_abnormal_immune_system | 0.97495300 |
| 111 | MP0000767_abnormal_smooth_muscle | 0.97269198 |
| 112 | MP0001819_abnormal_immune_cell | 0.97247976 |
| 113 | MP0005166_decreased_susceptibility_to | 0.96507570 |
| 114 | MP0002420_abnormal_adaptive_immunity | 0.96320202 |
| 115 | MP0001879_abnormal_lymphatic_vessel | 0.96022388 |
| 116 | MP0002396_abnormal_hematopoietic_system | 0.95948390 |
| 117 | MP0010329_abnormal_lipoprotein_level | 0.95090904 |
| 118 | MP0002429_abnormal_blood_cell | 0.95077860 |
| 119 | MP0008874_decreased_physiological_sensi | 0.94121432 |
| 120 | MP0008877_abnormal_DNA_methylation | 0.93738628 |
| 121 | MP0002009_preneoplasia | 0.93288540 |
| 122 | MP0002419_abnormal_innate_immunity | 0.91965089 |
| 123 | MP0002736_abnormal_nociception_after | 0.91854911 |
| 124 | MP0005647_abnormal_sex_gland | 0.91626910 |
| 125 | MP0005332_abnormal_amino_acid | 0.91371353 |
| 126 | MP0006082_CNS_inflammation | 0.90605035 |
| 127 | MP0003635_abnormal_synaptic_transmissio | 0.90507341 |
| 128 | MP0009785_altered_susceptibility_to | 0.90357162 |
| 129 | MP0010155_abnormal_intestine_physiology | 0.90092790 |
| 130 | MP0003329_amyloid_beta_deposits | 0.89444526 |
| 131 | MP0001849_ear_inflammation | 0.89363239 |
| 132 | MP0001800_abnormal_humoral_immune | 0.88855001 |
| 133 | MP0002085_abnormal_embryonic_tissue | 0.87575616 |
| 134 | MP0009703_decreased_birth_body | 0.86606222 |
| 135 | MP0005621_abnormal_cell_physiology | 0.86594821 |
| 136 | MP0005275_abnormal_skin_tensile | 0.86267871 |
| 137 | MP0003690_abnormal_glial_cell | 0.85294941 |
| 138 | MP0005535_abnormal_body_temperature | 0.85019892 |
| 139 | MP0001533_abnormal_skeleton_physiology | 0.84946633 |
| 140 | MP0001216_abnormal_epidermal_layer | 0.83668145 |
| 141 | MP0008875_abnormal_xenobiotic_pharmacok | 0.82991077 |
| 142 | MP0003045_fibrosis | 0.81644278 |
| 143 | MP0001915_intracranial_hemorrhage | 0.81037678 |
| 144 | MP0002084_abnormal_developmental_patter | 0.80187288 |
| 145 | MP0002452_abnormal_antigen_presenting | 0.79967148 |
| 146 | MP0005025_abnormal_response_to | 0.79070091 |
| 147 | MP0010234_abnormal_vibrissa_follicle | 0.78639435 |
| 148 | MP0002006_tumorigenesis | 0.78592047 |
| 149 | MP0004264_abnormal_extraembryonic_tissu | 0.78526760 |
| 150 | MP0002933_joint_inflammation | 0.78213065 |
| 151 | MP0003567_abnormal_fetal_cardiomyocyte | 0.77991935 |
| 152 | MP0005501_abnormal_skin_physiology | 0.77787227 |
| 153 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.77427248 |
| 154 | MP0009046_muscle_twitch | 0.77061958 |
| 155 | MP0004270_analgesia | 0.76669219 |
| 156 | MP0001845_abnormal_inflammatory_respons | 0.75064976 |
| 157 | MP0001853_heart_inflammation | 0.75063229 |
| 158 | MP0001958_emphysema | 0.74914900 |
| 159 | MP0000609_abnormal_liver_physiology | 0.74617365 |
| 160 | MP0002063_abnormal_learning/memory/cond | 0.74558293 |
| 161 | MP0002019_abnormal_tumor_incidence | 0.74204923 |
| 162 | MP0002909_abnormal_adrenal_gland | 0.71882139 |
| 163 | MP0003172_abnormal_lysosome_physiology | 0.71566199 |
| 164 | MP0002118_abnormal_lipid_homeostasis | 0.70710704 |
| 165 | MP0000858_altered_metastatic_potential | 0.70469330 |
| 166 | MP0005451_abnormal_body_composition | 0.70463705 |
| 167 | MP0003633_abnormal_nervous_system | 0.69893263 |
| 168 | MP0005666_abnormal_adipose_tissue | 0.69276876 |
| 169 | MP0001756_abnormal_urination | 0.69215201 |
| 170 | MP0002723_abnormal_immune_serum | 0.68990831 |
| 171 | MP0000249_abnormal_blood_vessel | 0.68938503 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 4.68311562 |
| 2 | Multiple enchondromatosis (HP:0005701) | 3.63733362 |
| 3 | Right ventricular cardiomyopathy (HP:0011663) | 3.36844890 |
| 4 | Ventricular tachycardia (HP:0004756) | 3.24036221 |
| 5 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.21920786 |
| 6 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.21731009 |
| 7 | Myocardial infarction (HP:0001658) | 3.09115542 |
| 8 | Chromsome breakage (HP:0040012) | 3.06493562 |
| 9 | Atrial fibrillation (HP:0005110) | 3.06116140 |
| 10 | Disinhibition (HP:0000734) | 3.05909811 |
| 11 | Cortical dysplasia (HP:0002539) | 3.02128934 |
| 12 | Gastrointestinal carcinoma (HP:0002672) | 2.91991499 |
| 13 | Malignant gastrointestinal tract tumors (HP:0006749) | 2.91991499 |
| 14 | Nephroblastoma (Wilms tumor) (HP:0002667) | 2.90940648 |
| 15 | Primary atrial arrhythmia (HP:0001692) | 2.89724385 |
| 16 | Deep venous thrombosis (HP:0002625) | 2.86291986 |
| 17 | Syncope (HP:0001279) | 2.81831849 |
| 18 | IgA deficiency (HP:0002720) | 2.78741626 |
| 19 | Leiomyosarcoma (HP:0100243) | 2.78270316 |
| 20 | Uterine leiomyosarcoma (HP:0002891) | 2.78270316 |
| 21 | Poikilocytosis (HP:0004447) | 2.76339819 |
| 22 | Transitional cell carcinoma of the bladder (HP:0006740) | 2.75250036 |
| 23 | Eczematoid dermatitis (HP:0000976) | 2.73884840 |
| 24 | Embryonal renal neoplasm (HP:0011794) | 2.70376460 |
| 25 | Hyporeflexia of lower limbs (HP:0002600) | 2.69941571 |
| 26 | Supraventricular tachycardia (HP:0004755) | 2.64557186 |
| 27 | Asymmetric septal hypertrophy (HP:0001670) | 2.64005963 |
| 28 | Reticulocytopenia (HP:0001896) | 2.63861290 |
| 29 | Abnormality of chromosome stability (HP:0003220) | 2.61779697 |
| 30 | Agnosia (HP:0010524) | 2.61250625 |
| 31 | Supraventricular arrhythmia (HP:0005115) | 2.61170983 |
| 32 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.55460607 |
| 33 | Hereditary nonpolyposis colorectal carcinoma (HP:0006716) | 2.53816454 |
| 34 | Xanthomatosis (HP:0000991) | 2.53201148 |
| 35 | Systemic lupus erythematosus (HP:0002725) | 2.51204897 |
| 36 | Bladder carcinoma (HP:0002862) | 2.50425407 |
| 37 | Bladder neoplasm (HP:0009725) | 2.50425407 |
| 38 | Abnormality of the fingertips (HP:0001211) | 2.50167782 |
| 39 | Complement deficiency (HP:0004431) | 2.46335254 |
| 40 | Exercise-induced muscle cramps (HP:0003710) | 2.44793227 |
| 41 | Supranuclear gaze palsy (HP:0000605) | 2.43544773 |
| 42 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.42509502 |
| 43 | Conjunctival hamartoma (HP:0100780) | 2.38074740 |
| 44 | Exercise-induced myalgia (HP:0003738) | 2.37739766 |
| 45 | Lipoatrophy (HP:0100578) | 2.35988282 |
| 46 | Septo-optic dysplasia (HP:0100842) | 2.34575915 |
| 47 | Abnormality of the calf musculature (HP:0001430) | 2.34264952 |
| 48 | Bundle branch block (HP:0011710) | 2.34238089 |
| 49 | Cerebral aneurysm (HP:0004944) | 2.33822693 |
| 50 | Prolonged QT interval (HP:0001657) | 2.32368953 |
| 51 | Limb hypertonia (HP:0002509) | 2.31248080 |
| 52 | Spastic diplegia (HP:0001264) | 2.30718876 |
| 53 | Meckel diverticulum (HP:0002245) | 2.30700103 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.30572460 |
| 55 | Abnormality of proline metabolism (HP:0010907) | 2.30572460 |
| 56 | Progressive external ophthalmoplegia (HP:0000590) | 2.30087931 |
| 57 | Ventricular arrhythmia (HP:0004308) | 2.25235272 |
| 58 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.24944152 |
| 59 | Thick nail (HP:0001805) | 2.24541294 |
| 60 | Calf muscle hypertrophy (HP:0008981) | 2.22635731 |
| 61 | T lymphocytopenia (HP:0005403) | 2.21865732 |
| 62 | Mitral stenosis (HP:0001718) | 2.21804200 |
| 63 | Axonal loss (HP:0003447) | 2.21415239 |
| 64 | Inappropriate behavior (HP:0000719) | 2.20496082 |
| 65 | Esophageal varix (HP:0002040) | 2.19559862 |
| 66 | Subacute progressive viral hepatitis (HP:0006572) | 2.18998706 |
| 67 | Deep palmar crease (HP:0006191) | 2.18911786 |
| 68 | Myokymia (HP:0002411) | 2.18601822 |
| 69 | Dysmetric saccades (HP:0000641) | 2.18404864 |
| 70 | Ventricular fibrillation (HP:0001663) | 2.16623819 |
| 71 | Lymphangioma (HP:0100764) | 2.16514631 |
| 72 | Abnormality of the ileum (HP:0001549) | 2.16285873 |
| 73 | Cerebral hemorrhage (HP:0001342) | 2.15878137 |
| 74 | Recurrent viral infections (HP:0004429) | 2.13954684 |
| 75 | Uterine neoplasm (HP:0010784) | 2.12329730 |
| 76 | Dysphonia (HP:0001618) | 2.09641031 |
| 77 | IgM deficiency (HP:0002850) | 2.09375305 |
| 78 | Autoimmune hemolytic anemia (HP:0001890) | 2.08914279 |
| 79 | Increased connective tissue (HP:0009025) | 2.08182400 |
| 80 | Abnormal hair whorl (HP:0010721) | 2.06448239 |
| 81 | Colon cancer (HP:0003003) | 2.05463715 |
| 82 | Action tremor (HP:0002345) | 2.05203554 |
| 83 | Ketoacidosis (HP:0001993) | 2.01962444 |
| 84 | Homocystinuria (HP:0002156) | 2.01450591 |
| 85 | Abnormality of homocysteine metabolism (HP:0010919) | 2.01450591 |
| 86 | Birth length less than 3rd percentile (HP:0003561) | 2.00940502 |
| 87 | Embryonal neoplasm (HP:0002898) | 1.99248684 |
| 88 | Polycythemia (HP:0001901) | 1.98921308 |
| 89 | Increased IgM level (HP:0003496) | 1.98907516 |
| 90 | Abnormality of the preputium (HP:0100587) | 1.98714322 |
| 91 | Acute lymphatic leukemia (HP:0006721) | 1.98518453 |
| 92 | Aortic aneurysm (HP:0004942) | 1.98392453 |
| 93 | Mitral valve prolapse (HP:0001634) | 1.96183502 |
| 94 | Hepatoblastoma (HP:0002884) | 1.95953006 |
| 95 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.95145708 |
| 96 | Ankyloglossia (HP:0010296) | 1.94133996 |
| 97 | Myotonia (HP:0002486) | 1.93730686 |
| 98 | Abnormality of T cell number (HP:0011839) | 1.93674392 |
| 99 | Long palpebral fissure (HP:0000637) | 1.93633031 |
| 100 | Hematochezia (HP:0002573) | 1.93331870 |
| 101 | Pheochromocytoma (HP:0002666) | 1.92918714 |
| 102 | Abnormal atrioventricular conduction (HP:0005150) | 1.92682947 |
| 103 | Acanthocytosis (HP:0001927) | 1.92544760 |
| 104 | Hamartoma of the eye (HP:0010568) | 1.92261900 |
| 105 | Heart block (HP:0012722) | 1.91632065 |
| 106 | EMG: myopathic abnormalities (HP:0003458) | 1.91621296 |
| 107 | Nephritis (HP:0000123) | 1.91403712 |
| 108 | Atrioventricular block (HP:0001678) | 1.91262003 |
| 109 | Combined immunodeficiency (HP:0005387) | 1.91245092 |
| 110 | Subaortic stenosis (HP:0001682) | 1.90551130 |
| 111 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.90551130 |
| 112 | Choanal stenosis (HP:0000452) | 1.89454843 |
| 113 | Short middle phalanx of the 5th finger (HP:0004220) | 1.89355591 |
| 114 | Skull defect (HP:0001362) | 1.88997104 |
| 115 | Autoimmune thrombocytopenia (HP:0001973) | 1.88079193 |
| 116 | Asymmetry of the thorax (HP:0001555) | 1.87321175 |
| 117 | Increased nuchal translucency (HP:0010880) | 1.86805918 |
| 118 | Cafe-au-lait spot (HP:0000957) | 1.86764654 |
| 119 | Abnormality of reticulocytes (HP:0004312) | 1.86141228 |
| 120 | Peritonitis (HP:0002586) | 1.85741799 |
| 121 | Amaurosis fugax (HP:0100576) | 1.85622982 |
| 122 | Long toe (HP:0010511) | 1.85451134 |
| 123 | Hyperlipoproteinemia (HP:0010980) | 1.85376535 |
| 124 | Sudden cardiac death (HP:0001645) | 1.85257329 |
| 125 | Neoplasm of the adrenal cortex (HP:0100641) | 1.84774720 |
| 126 | Paralysis (HP:0003470) | 1.84758676 |
| 127 | Hypoalphalipoproteinemia (HP:0003233) | 1.84159970 |
| 128 | Abnormality of complement system (HP:0005339) | 1.81974083 |
| 129 | Selective tooth agenesis (HP:0001592) | 1.81873695 |
| 130 | Cellular immunodeficiency (HP:0005374) | 1.81501210 |
| 131 | Abnormality of the salivary glands (HP:0010286) | 1.81322859 |
| 132 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.80969850 |
| 133 | Wide nose (HP:0000445) | 1.80862290 |
| 134 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.80726526 |
| 135 | Abnormality of the septum pellucidum (HP:0007375) | 1.80365323 |
| 136 | Lymphopenia (HP:0001888) | 1.80172252 |
| 137 | Carpal bone hypoplasia (HP:0001498) | 1.79639888 |
| 138 | Hepatocellular carcinoma (HP:0001402) | 1.79501223 |
| 139 | Myoglobinuria (HP:0002913) | 1.78579153 |
| 140 | Abnormality of the lumbar spine (HP:0100712) | 1.78504891 |
| 141 | Palpitations (HP:0001962) | 1.78464519 |
| 142 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.77649941 |
| 143 | Ketosis (HP:0001946) | 1.77513811 |
| 144 | Long eyelashes (HP:0000527) | 1.77505581 |
| 145 | Neonatal hypoglycemia (HP:0001998) | 1.77207847 |
| 146 | Skin nodule (HP:0200036) | 1.76222808 |
| 147 | Osteomyelitis (HP:0002754) | 1.75933312 |
| 148 | Thoracic kyphosis (HP:0002942) | 1.75799738 |
| 149 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.74836900 |
| 150 | Renal cell carcinoma (HP:0005584) | 1.74800154 |
| 151 | Maternal diabetes (HP:0009800) | 1.74233431 |
| 152 | Rhabdomyosarcoma (HP:0002859) | 1.74158627 |
| 153 | Thickened helices (HP:0000391) | 1.73864011 |
| 154 | Pallor (HP:0000980) | 1.73767628 |
| 155 | Recurrent bacterial skin infections (HP:0005406) | 1.72769784 |
| 156 | Epidermoid cyst (HP:0200040) | 1.72479684 |
| 157 | Cleft eyelid (HP:0000625) | 1.71485993 |
| 158 | Intrahepatic cholestasis (HP:0001406) | 1.70720161 |
| 159 | Abnormality of the thoracic spine (HP:0100711) | 1.70362484 |
| 160 | Optic neuritis (HP:0100653) | 1.70061643 |
| 161 | Retrobulbar optic neuritis (HP:0100654) | 1.70061643 |
| 162 | Anal stenosis (HP:0002025) | 1.69074551 |
| 163 | Dilated cardiomyopathy (HP:0001644) | 1.66845386 |
| 164 | Aneurysm (HP:0002617) | 1.66590702 |
| 165 | Urethral obstruction (HP:0000796) | 1.66139212 |
| 166 | Abnormality of the Achilles tendon (HP:0005109) | 1.65825654 |
| 167 | Arterial thrombosis (HP:0004420) | 1.65477583 |
| 168 | Stroke (HP:0001297) | 1.65397339 |
| 169 | Joint hemorrhage (HP:0005261) | 1.64855032 |
| 170 | Lower limb amyotrophy (HP:0007210) | 1.64399892 |
| 171 | Lymphoma (HP:0002665) | 1.64355374 |
| 172 | Abnormal lung lobation (HP:0002101) | 1.64326830 |
| 173 | Glomerulonephritis (HP:0000099) | 1.63345706 |
| 174 | Short middle phalanx of finger (HP:0005819) | 1.63089793 |
| 175 | Hypochromic microcytic anemia (HP:0004840) | 1.62950055 |
| 176 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.62799828 |
| 177 | Cavernous hemangioma (HP:0001048) | 1.62576566 |
| 178 | Overgrowth (HP:0001548) | 1.61253955 |
| 179 | Recurrent fungal infections (HP:0002841) | 1.60522842 |
| 180 | Increased cerebral lipofuscin (HP:0011813) | 1.59368603 |
| 181 | Persistence of primary teeth (HP:0006335) | 1.58815534 |
| 182 | Mediastinal lymphadenopathy (HP:0100721) | 1.58247056 |
| 183 | Muscle fiber splitting (HP:0003555) | 1.57989500 |
| 184 | Lower limb asymmetry (HP:0100559) | 1.57488441 |
| 185 | Neuroendocrine neoplasm (HP:0100634) | 1.56788327 |
| 186 | Striae distensae (HP:0001065) | 1.55604965 |
| 187 | Sensorimotor neuropathy (HP:0007141) | 1.55342743 |
| 188 | Focal seizures (HP:0007359) | 1.55176415 |
| 189 | Frequent falls (HP:0002359) | 1.55142081 |
| 190 | Distal lower limb muscle weakness (HP:0009053) | 1.54423210 |
| 191 | Ectopia lentis (HP:0001083) | 1.54226066 |
| 192 | Abnormal EKG (HP:0003115) | 1.53848913 |
| 193 | Dilatation of the ascending aorta (HP:0005111) | 1.53783848 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PRPF4B | 3.40821088 |
| 2 | CDC7 | 2.82326554 |
| 3 | MAP3K14 | 2.67119847 |
| 4 | TRIB3 | 2.61115728 |
| 5 | IRAK3 | 2.60572733 |
| 6 | PKN2 | 2.15968688 |
| 7 | TTK | 2.13361255 |
| 8 | TAOK2 | 2.09996674 |
| 9 | BUB1 | 2.06821922 |
| 10 | TTN | 2.06566419 |
| 11 | JAK1 | 2.04346450 |
| 12 | EEF2K | 2.02594366 |
| 13 | CDK12 | 1.99466175 |
| 14 | SMG1 | 1.98704073 |
| 15 | TYK2 | 1.98567641 |
| 16 | RIPK1 | 1.90915157 |
| 17 | TSSK6 | 1.90020502 |
| 18 | EIF2AK1 | 1.87764402 |
| 19 | RIPK4 | 1.87712517 |
| 20 | FGFR4 | 1.87410116 |
| 21 | MST4 | 1.85264549 |
| 22 | JAK3 | 1.80381644 |
| 23 | NME2 | 1.77202213 |
| 24 | TAF1 | 1.66537688 |
| 25 | TBK1 | 1.62349839 |
| 26 | MAP3K9 | 1.61063839 |
| 27 | SIK1 | 1.58511264 |
| 28 | ACVR1B | 1.56130658 |
| 29 | CLK1 | 1.55503218 |
| 30 | DYRK3 | 1.54250781 |
| 31 | SIK2 | 1.52549500 |
| 32 | MAP3K13 | 1.52539857 |
| 33 | EPHA3 | 1.50045591 |
| 34 | DMPK | 1.48806244 |
| 35 | MKNK2 | 1.48667131 |
| 36 | STK24 | 1.42789716 |
| 37 | LMTK2 | 1.42690770 |
| 38 | PHKG1 | 1.41834919 |
| 39 | PHKG2 | 1.41834919 |
| 40 | FGFR3 | 1.41397478 |
| 41 | EIF2AK3 | 1.36060942 |
| 42 | PASK | 1.35696141 |
| 43 | CDK4 | 1.35547183 |
| 44 | MKNK1 | 1.34813072 |
| 45 | TYRO3 | 1.34537578 |
| 46 | PLK4 | 1.31524852 |
| 47 | RET | 1.30479419 |
| 48 | SGK3 | 1.29518028 |
| 49 | BRAF | 1.28010491 |
| 50 | PTK6 | 1.26921975 |
| 51 | PLK3 | 1.26226261 |
| 52 | NLK | 1.23641560 |
| 53 | ICK | 1.21133061 |
| 54 | STK4 | 1.20302087 |
| 55 | MAP3K7 | 1.18379986 |
| 56 | DAPK2 | 1.17895771 |
| 57 | KSR2 | 1.17626269 |
| 58 | MAP3K8 | 1.15310554 |
| 59 | TGFBR2 | 1.14301986 |
| 60 | MYLK | 1.13389832 |
| 61 | MINK1 | 1.09878582 |
| 62 | PRKCH | 1.09470894 |
| 63 | NTRK3 | 1.07522399 |
| 64 | SGK2 | 1.07274016 |
| 65 | TNIK | 1.07074978 |
| 66 | PIM1 | 1.06110459 |
| 67 | JAK2 | 1.05994506 |
| 68 | FGR | 1.04827230 |
| 69 | SRPK1 | 1.04587645 |
| 70 | MELK | 1.02421632 |
| 71 | STK10 | 1.01766522 |
| 72 | MAP2K4 | 0.99437814 |
| 73 | IKBKE | 0.98835101 |
| 74 | CAMK1G | 0.98055628 |
| 75 | CHUK | 0.97444095 |
| 76 | MAP4K1 | 0.97440188 |
| 77 | BRD4 | 0.97304910 |
| 78 | PBK | 0.96141270 |
| 79 | EPHB1 | 0.93357412 |
| 80 | ERN1 | 0.92596614 |
| 81 | CHEK2 | 0.91755785 |
| 82 | WEE1 | 0.91466561 |
| 83 | NTRK2 | 0.90124939 |
| 84 | CAMK1D | 0.89927659 |
| 85 | CAMKK1 | 0.89307479 |
| 86 | STK16 | 0.88153611 |
| 87 | OBSCN | 0.86451380 |
| 88 | IKBKB | 0.85367478 |
| 89 | NTRK1 | 0.84442646 |
| 90 | PIK3CA | 0.84160464 |
| 91 | NEK9 | 0.83575299 |
| 92 | STK38 | 0.83368873 |
| 93 | CDK6 | 0.83206247 |
| 94 | MARK3 | 0.83043196 |
| 95 | PTK2B | 0.82836000 |
| 96 | MARK1 | 0.82160805 |
| 97 | PAK3 | 0.80003481 |
| 98 | STK3 | 0.79922493 |
| 99 | ALK | 0.79619744 |
| 100 | MST1R | 0.79394019 |
| 101 | TAOK1 | 0.78373381 |
| 102 | PKN1 | 0.77859809 |
| 103 | CHEK1 | 0.77830417 |
| 104 | MATK | 0.77282484 |
| 105 | MAPK12 | 0.76833824 |
| 106 | PDGFRA | 0.76235667 |
| 107 | GRK5 | 0.75152331 |
| 108 | ZAK | 0.74770013 |
| 109 | LRRK2 | 0.73771424 |
| 110 | SIK3 | 0.73070953 |
| 111 | PLK1 | 0.72220269 |
| 112 | BMX | 0.71745009 |
| 113 | PAK6 | 0.71739442 |
| 114 | GRK7 | 0.71230154 |
| 115 | PRKCQ | 0.70597865 |
| 116 | IRAK4 | 0.70595168 |
| 117 | CAMK4 | 0.70064896 |
| 118 | MAP3K2 | 0.69432995 |
| 119 | MAP3K5 | 0.68943650 |
| 120 | HCK | 0.68587588 |
| 121 | RPS6KA2 | 0.68191683 |
| 122 | EPHB2 | 0.68190664 |
| 123 | SGK494 | 0.67447867 |
| 124 | SGK223 | 0.67447867 |
| 125 | ARAF | 0.67424250 |
| 126 | DDR2 | 0.66761020 |
| 127 | CDC42BPA | 0.65643825 |
| 128 | WNK1 | 0.65231755 |
| 129 | IRAK2 | 0.64637446 |
| 130 | TRPM7 | 0.64426611 |
| 131 | ROCK1 | 0.64373389 |
| 132 | ATR | 0.61968281 |
| 133 | MAP3K1 | 0.60817685 |
| 134 | PRKD1 | 0.58895252 |
| 135 | MTOR | 0.58846488 |
| 136 | PNCK | 0.58385190 |
| 137 | YES1 | 0.58326204 |
| 138 | SGK1 | 0.58124830 |
| 139 | MAP3K10 | 0.57797181 |
| 140 | CDK7 | 0.57645660 |
| 141 | EGFR | 0.57069705 |
| 142 | PDK1 | 0.56590600 |
| 143 | NEK1 | 0.56435339 |
| 144 | ATM | 0.56189587 |
| 145 | FGFR2 | 0.55776565 |
| 146 | ITK | 0.55566494 |
| 147 | INSRR | 0.55417870 |
| 148 | PRKAA2 | 0.55105108 |
| 149 | EIF2AK2 | 0.53280252 |
| 150 | FER | 0.53196179 |
| 151 | MAP2K3 | 0.53052932 |
| 152 | MAP3K4 | 0.52288889 |
| 153 | FGFR1 | 0.51527096 |
| 154 | STK11 | 0.51342331 |
| 155 | BLK | 0.51297921 |
| 156 | LATS2 | 0.50580385 |
| 157 | PDPK1 | 0.50038341 |
| 158 | PDGFRB | 0.49583522 |
| 159 | PRKCZ | 0.49153090 |
| 160 | TGFBR1 | 0.48845829 |
| 161 | MAP3K3 | 0.47982816 |
| 162 | PLK2 | 0.47103327 |
| 163 | SYK | 0.45757388 |
| 164 | TXK | 0.45166620 |
| 165 | PRKCE | 0.44131155 |
| 166 | DAPK3 | 0.43998385 |
| 167 | CDK5 | 0.43671747 |
| 168 | CDK2 | 0.42933740 |
| 169 | CSK | 0.39588592 |
| 170 | MAP3K11 | 0.38817245 |
| 171 | CDK9 | 0.37750269 |
| 172 | RPS6KB2 | 0.37122666 |
| 173 | PAK4 | 0.36881991 |
| 174 | KSR1 | 0.34890853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.44381918 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.11420030 |
| 3 | Cell cycle_Homo sapiens_hsa04110 | 2.61774303 |
| 4 | Mismatch repair_Homo sapiens_hsa03430 | 2.58499083 |
| 5 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.49409293 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.27006581 |
| 7 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.85164187 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.83755478 |
| 9 | Spliceosome_Homo sapiens_hsa03040 | 1.79957082 |
| 10 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.74259376 |
| 11 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.56712348 |
| 12 | RNA transport_Homo sapiens_hsa03013 | 1.56351736 |
| 13 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 1.53845246 |
| 14 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.52551130 |
| 15 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.51070394 |
| 16 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.49561432 |
| 17 | Thyroid cancer_Homo sapiens_hsa05216 | 1.49408645 |
| 18 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.48555998 |
| 19 | Prostate cancer_Homo sapiens_hsa05215 | 1.45292689 |
| 20 | Hepatitis B_Homo sapiens_hsa05161 | 1.44525944 |
| 21 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.43365290 |
| 22 | Influenza A_Homo sapiens_hsa05164 | 1.42367100 |
| 23 | Base excision repair_Homo sapiens_hsa03410 | 1.36614193 |
| 24 | Bladder cancer_Homo sapiens_hsa05219 | 1.35833186 |
| 25 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.34451043 |
| 26 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.32596261 |
| 27 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.31221628 |
| 28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.28358618 |
| 29 | Ribosome_Homo sapiens_hsa03010 | 1.27857685 |
| 30 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.25400774 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.24238861 |
| 32 | Apoptosis_Homo sapiens_hsa04210 | 1.24089698 |
| 33 | Hepatitis C_Homo sapiens_hsa05160 | 1.23019493 |
| 34 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.21947316 |
| 35 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.18917224 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.17414776 |
| 37 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.16633714 |
| 38 | Homologous recombination_Homo sapiens_hsa03440 | 1.15339154 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 1.11584367 |
| 40 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10664659 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.10406605 |
| 42 | Leishmaniasis_Homo sapiens_hsa05140 | 1.09506020 |
| 43 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.06120712 |
| 44 | Viral carcinogenesis_Homo sapiens_hsa05203 | 1.05591303 |
| 45 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.05193444 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.04158886 |
| 47 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.03587580 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.02921269 |
| 49 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.00464924 |
| 50 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.00391660 |
| 51 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.99459118 |
| 52 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.98745703 |
| 53 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.98454010 |
| 54 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96729640 |
| 55 | Insulin resistance_Homo sapiens_hsa04931 | 0.96386275 |
| 56 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.96124387 |
| 57 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.95256169 |
| 58 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.93524865 |
| 59 | Adherens junction_Homo sapiens_hsa04520 | 0.93377521 |
| 60 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.93366933 |
| 61 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.92785061 |
| 62 | RNA degradation_Homo sapiens_hsa03018 | 0.92237217 |
| 63 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.91930936 |
| 64 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.91520505 |
| 65 | Legionellosis_Homo sapiens_hsa05134 | 0.90163057 |
| 66 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.88112653 |
| 67 | Basal transcription factors_Homo sapiens_hsa03022 | 0.85951630 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.85686151 |
| 69 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.84789412 |
| 70 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.84185749 |
| 71 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.83931211 |
| 72 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83795472 |
| 73 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.83536797 |
| 74 | Tuberculosis_Homo sapiens_hsa05152 | 0.83363953 |
| 75 | Asthma_Homo sapiens_hsa05310 | 0.82778025 |
| 76 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.82730061 |
| 77 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.82626218 |
| 78 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.82599676 |
| 79 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.82144240 |
| 80 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.82042870 |
| 81 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.82040300 |
| 82 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.81684571 |
| 83 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.80946461 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.80455812 |
| 85 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.80395988 |
| 86 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80290357 |
| 87 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79996079 |
| 88 | Circadian entrainment_Homo sapiens_hsa04713 | 0.78528598 |
| 89 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.77952178 |
| 90 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.76604065 |
| 91 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.76436876 |
| 92 | Colorectal cancer_Homo sapiens_hsa05210 | 0.76162582 |
| 93 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.73821769 |
| 94 | Amoebiasis_Homo sapiens_hsa05146 | 0.73769935 |
| 95 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.73726504 |
| 96 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.72531677 |
| 97 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.72409141 |
| 98 | Glioma_Homo sapiens_hsa05214 | 0.71970126 |
| 99 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.71958465 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.71636312 |
| 101 | Long-term potentiation_Homo sapiens_hsa04720 | 0.71321191 |
| 102 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.71240062 |
| 103 | Olfactory transduction_Homo sapiens_hsa04740 | 0.71130945 |
| 104 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70974419 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.70516451 |
| 106 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.70511941 |
| 107 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.70303918 |
| 108 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.69189968 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.68973721 |
| 110 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.68827381 |
| 111 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.68096289 |
| 112 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.67719405 |
| 113 | Pertussis_Homo sapiens_hsa05133 | 0.67006688 |
| 114 | Lysosome_Homo sapiens_hsa04142 | 0.66450925 |
| 115 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.66159937 |
| 116 | Lysine degradation_Homo sapiens_hsa00310 | 0.65216434 |
| 117 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.63584954 |
| 118 | RNA polymerase_Homo sapiens_hsa03020 | 0.63484799 |
| 119 | Shigellosis_Homo sapiens_hsa05131 | 0.63158934 |
| 120 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.62729057 |
| 121 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.62647475 |
| 122 | Allograft rejection_Homo sapiens_hsa05330 | 0.62522557 |
| 123 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.62363380 |
| 124 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.62316675 |
| 125 | Proteasome_Homo sapiens_hsa03050 | 0.62050745 |
| 126 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.62025738 |
| 127 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.60525153 |
| 128 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.60243672 |
| 129 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.59502632 |
| 130 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.59340223 |
| 131 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.59314623 |
| 132 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.58924339 |
| 133 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.58705339 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.58345952 |
| 135 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58012972 |
| 136 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.57746130 |
| 137 | Measles_Homo sapiens_hsa05162 | 0.57634618 |
| 138 | Focal adhesion_Homo sapiens_hsa04510 | 0.57402591 |
| 139 | Salmonella infection_Homo sapiens_hsa05132 | 0.57105095 |
| 140 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.55738102 |
| 141 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.55526262 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.55485216 |
| 143 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.55404871 |
| 144 | Malaria_Homo sapiens_hsa05144 | 0.55313614 |
| 145 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.54602562 |
| 146 | Prion diseases_Homo sapiens_hsa05020 | 0.54422874 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53472110 |
| 148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53178526 |
| 149 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.53042108 |
| 150 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.52511122 |
| 151 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52246348 |
| 152 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.52168424 |
| 153 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.52131505 |
| 154 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.51872445 |
| 155 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.51871443 |
| 156 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.51452847 |
| 157 | Morphine addiction_Homo sapiens_hsa05032 | 0.50653396 |
| 158 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.50643245 |
| 159 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.50541630 |
| 160 | Insulin secretion_Homo sapiens_hsa04911 | 0.50476736 |
| 161 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.49765079 |
| 162 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.48963027 |
| 163 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.48628110 |
| 164 | GABAergic synapse_Homo sapiens_hsa04727 | 0.48033255 |
| 165 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.47948505 |
| 166 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.47624036 |
| 167 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.47506823 |
| 168 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.47166934 |
| 169 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.47111907 |

